** Shares of Atomo Diagnostics AT1.AX rise 6.3% to A$0.017
** Stock set for its strongest session since January 31, if current trend holds
** Medical device co says Thorne Harbour Health has placed an order worth ~230,000 for co's HIV self-tests to support initial national scale up of its CONNECT program
** Says HIV self-tests to be imported into New Zealand with launch of product through Chemist Warehouse
** 659,024 shares traded in stock's busiest session since March 11
** Stock down 10.5% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。